nivolumab,ipilimumab
bms
['lcsm,(-blcsm)', 'friends', '9la']
9la 3y os. 27% alive at 3y. it s 33% in both pdl1+ and - of cm227. this really looks good and i hear good reports from my us onc friends who use it. #asco22 #lcsm 
Consultant Medical Oncologist, UK. Views are hypothesis generating discourse. Post COVID dabbling in garden.